<p>Pfizer Inc and United Nations-backed Medicines Patent Pool (MPP) are in advanced talks on a licensing agreement that would allow qualified third parties to manufacture and supply the US drugmaker's oral antiviral pill candidate, pending regulatory nod, the MPP told <em>Reuters.</em></p>.<p><strong>Check out DH's latest videos:</strong></p>
<p>Pfizer Inc and United Nations-backed Medicines Patent Pool (MPP) are in advanced talks on a licensing agreement that would allow qualified third parties to manufacture and supply the US drugmaker's oral antiviral pill candidate, pending regulatory nod, the MPP told <em>Reuters.</em></p>.<p><strong>Check out DH's latest videos:</strong></p>